Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.

Feng W , Wu K , Liu Z , Kong G , Deng Z , Chen S , Wu Y , Chen M , Liu S , Wang H
Thrombosis research
To analyze the efficacy and safety of direct factor Xa inhibitors for thromboprophylaxis after total hip or knee replacement. To delineate the dose response effect of direct factor Xa inhibitors. To compare the efficacy between any two direct factor Xa inhibitors.

Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved